MedPath

The effect of cognitive behavioral therapy on stress, anxiety and depressio

Not Applicable
Conditions
multiple sclerosis.
Multiple sclerosis
Registration Number
IRCT2015012720833N1
Lead Sponsor
Research center of Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
70
Inclusion Criteria

a definite diagnosis of multiple sclerosis by a neurologist and a minimum of six months from the time it is diagnosed; any relapse during the past month; willingness to participate in the study; Previous participate in meetings of complementary medicine such as relaxation therapy, cognitive therapy, and etc until six months before the study ; having mild stress, anxiety and depression based on DASS-42 ; absence of mental and physical disease (acute and chronic) such as heart disease, kidney disease, severe depression, speech or hearing difficulties;any psychotropic drugs at least 3 months before treatment; non of medical staff (doctors, nurses, etc); lack of other complementary treatments such as physical therapy, acupuncture, yoga and psychotherapy sessions during the study; points 5.5- 0 expanded disability status scale (EDSS) Exclusion criteria: 1) lack of desire to continue cooperation in research; lack of attendance at meetings (an absence of more than two sessions) ; dealing with the crisis and the severe stress during the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Stress. Timepoint: Before the intervention,Immediately after the intervention,One month after the intervention. Method of measurement: DASS-42 questionnaire.;Anexiety. Timepoint: Before the intervention,Immediately after the intervention,One month after the intervention. Method of measurement: DASS-42 questionnaire.;Depression. Timepoint: Before the intervention,Immediately after the intervention,One month after the intervention. Method of measurement: DASS-42 questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath